Autoimmune diseases as well as type-I allergic diseases have markedly increased in the past 30 years. Environmental estrogens or endocrine disruptors are possibly involved in the etiology of the increase in autoimmune diseases as one of environmental factors. In aged BWF1 mice, a murine model for SLE, B lymphocyte chemoattractant (BLC! CXCL13) is ectopically and highly expressed in target organs such as the thymus and kidney. B1 cells, a specialized cell population that are distinguished from conventional B cells (B2 cells) by their origin, cell surface phenotype, unique tissue distribution, self-reactivity, etc., preferentially migrate towards BLC. Aberrant B1 cell trafficking to the target organs may result in activation of autoreactive CD4 T cells, autoantibody production, and impaired mucosal immunity in the gut during the development of SLE. Interestingly, B1 cells show a higher sensitivity to environmental estrogens than conventional B (B2) cells to produce autoantibodies. Thus, B1 cell can be a useful target for evaluating the pathological significance of environmental estrogens in the development of autoimmune diseases.
INTRODUCTION
A recent epidemiological study has revealed that approximately one third of the Japanese population is suffering from type-I allergic diseases including bronchial asthma, atopic dermatitis and allergic rhinitis. Environmental rather than genetic factors are likely involved in the marked increase in allergic diseases. In addition to environmental factors which directly affect the dose of allergens, it is pointed out that endocrine disruptors (ECDs) or environmental estrogens may be involved in the marked increase in allergic diseases.
It is well established that females have stronger immune responses than males . This phenomenon of gender-biased immune capability is largely attributed to the effects of sex hormones on the immune system. 1, 2 Estrogen regulates the synthesis of serum and uterine IgM , IgA , and IgG and enhances antibody production to several non-self and self antigens. 3, 4 It is also well known that women are more susceptible to autoimmune diseases than men. There is compelling evidence, both in human and animals, that sex hormones play a major role in autoimmune diseases, particularly in lupus. [5] [6] [7] The course of many autoimmune diseases is markedly affected during periods of physiological fluctuation in sex hormones ( that is , pregnancy or menopause). Since many endocrine disruptors possess estrogenic activity, it is likely that the effect of environmental estrogens, if any , would appear on the gender-biased diseases such as autoimmune diseases. 8 On the other hand, another epidemiological study has demonstrated that autoimmune diseases as well as type-I allergic diseases have been markedly increasing for the past 30 years (Fig. 1) . 9 It is generally F i g . 1 Ma r k e d i n c r e a s e o f a u t o i mmu n e d i s e a s e s i n J a p a n . Ch a n g e s f r o m.
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T h e n u mb e r s o f r e c i p i e n t s o f p e n s i o n f o r i n t r a c t a b l e d i s e a s e s i n c l u d i n g S L E ( ○) , My a s t h e n i a g r a v i s ( •) , De r ma t o my o s i t i s＋ S c l e r o d e r ma ( △) , I T P ( ▲) , ma l i g n a n t r h e u ma t o i d a r t h r i t i s ( □) h a v e b e e n i n c r e a s e d f o r t h e p a s t 3 0 y e a r s . [10] [11] [12] A marked mononuclear cell infiltration in the target organs including the kidney, thymus, and lung is another characteristic in SLE. Recent advances in molecular and biological analysis on chemokine ! chemokine receptors have revealed pivotal roles of these proteins in inflammatory cellular infiltration. 13 Chemokines and their receptors also play a pivotal role in linking innate immunity with acquired immunity through regulating dendritic cell trafficking. 14 Th1! Th2 balance is regulated by the chemokine! chemokine receptor system and dysregulation of the balance is a general feature of the onset, progression, and prognosis of autoimmune diseases. 15, 16 Using BWF 1 mice , a murine model for SLE, we have demonstrated that aberrant B1 cell trafficking to the target organs due to ectopic expression of BLC! CXCL13 plays an important role in the pathogenesis of murine lupus. [17] [18] [19] [20] [21] These findings in a murine model for SLE and the epidemiological study showing a marked increase in the number of SLE patients in Japan prompted us to examine the effects of environmental estrogens on B1 cells. Our study has revealed that B1, but not B2 cells are susceptible to environmental estrogens and lead to the production of autoantibodies. 22 Possible roles of environmental estrogens in the development of SLE and necessity of screening system specialized for autoimmune diseases are discussed.
B1 CELLS IN INNATE AND ACQUIRED IM-MUNITY
B1 cells were first described in 1983 by Hayakawa et al. 23, 24 and suggested to be involved in the development of autoimmune diseases. B1 cells in the peritoneal cavity and spleen are increased in certain murine autoimmune models including NZB, NZB.H2bm12, moth-eaten mice and BWF1 mice. Likewise, elevated levels of B1 cells have been documented in patients with autoimmune disorders, notably in Sj! gren's syndrome and rheumatoid arthritis . 25, 26 Furthermore , down-regulation! elimination of B1 cells by either administration of anti-IL-10 antibody 27, 28 or intraperitoneal injection of distilled water delays the onset and severity of lupus nephritis in BWF1 mice. 29 It is further demonstrated that B 1 cells are involved in innate immunity by producing IgM antibodies against microbial antigens including phosphatidylcholine (PC), lipopolysaccharide (LPS), and α (1 3) dextran to eliminate blood borne-pathogens. IgM antibody produced by B1 cells also plays a role for prevention of certain viral infection. 30 On the other hand, F i g . 2 Ch a r a c t e r i s t i c s o f B 1 a n d B 2 c e l l s . B 1 c e l l s a r e d i s t i n c t f r o m c o n v e n t i o n a l B c e l l s ( B 2 c e l l s ) b y t h e i r o r i g i n , t i s s u e d i s t r i b u t i o n , c e l l s u rf a c e p h e n o t y p e s , a n t i g e n s p e c i f i c i t y a n d s o o n . T cell dependent High affinity antibody F i g . 3 E c t o p i c h i g h e x p r e s s i o n o f B L C i n t h e t a r g e t o r g a n s i n a g e d B WF 1 mi c e a n d p r e f e r e n t i a l c h e mo t a x i s o f B 1 c e l l s t o wa r d s B L C. Ch a n g e s f r o m. 1 
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S p l e e n o r p e r i t o n e a l c e l l s f r o m y o u n g B WF 1 mi c e we r e s t a i n e d f o r F I T C-l a b e l e d CD5 a n d P E -B 2 2 0 a n d s o r t e d i n t o B 1 a n d B 2 c e l l s . Ch e mo t a x i s a s s a y u s i n g Ch e mo T x p l a t e ( Ne u r o P r o b e , Ga i t h e r s b u r g , MD, US A ) wa s p e r f o r me d a c c o r d i n g t o ma n u f a c t u r e r ' s i n s t r u c t i o n s . Mi g r a t e d c e l l s we r e c o u n t e d o n a f l o w c yt o me t e r u n d e r t h e c o n s t a n t f l o w r a t e . accumulating data suggest that B1 cells play an important role in mucosal immunity in the gut. 31 Kroese et al. 32 previously reported that approximately half of IgA + B cells in the lamina propria in the intestinal mucosa were derived from B 1 cells . It has been also demonstrated that B1 cells produce IgA antibody in the presence of commensal microflora and contribute to prevention of systemic invasion by intestinal bacteria. 33 Another important feature of B1 cells is their potent antigen presenting ability. 20 
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The potent antigen presenting ability of B 1 cells is likely attributed to higher expression levels of accessory molecules including CD80, CD86, and ICAM-1 than that in B2 cells. Lanzavecchia et al. 35 reported that B cells could efficiently uptake the antigen through their surface immunoglobulin receptors , process, and then present it to specific T cells in a MHC-restricted manner. Since B1 cells often recognize self-antigens with low affinity and broad specificities, B1 cells would efficiently activate auto-reactive TCRs with low avidity . These findings suggest that B 1 cells play a pivotal role both in innate and acquired immunity (Fig. 2) .
ECTOPIC AND HIGH EXPRESSION OF B LYMPHOCYTE CHEMOATTRACTANT (BLC! CXCL13) AND PATHOLOGICAL SIGNIFI-CANCE OF B 1 CELLS IN THE DEVELOP-MENT OF SLE
B lymphocyte chemoattractant (BLC! CXCL13) is CXC chemokine which chemoattracts B cells and activated CD4 T cells expressing CXCR5, a receptor for BLC and is one of the homeostatic chemokines which is essential for lymphogenesis. 36 38 We found that BLC is highly expressed in the target organs including the thymus and kidney in aged BWF1 mice 17 ( Fig. 3A) . Interestingly, BLC chemoattracts B1 cells much more effectively than B2 cells probably due to higher expression of CXCR 5 on B 1 cells than B 2 cells 17 (Fig. 3B ). Ectopic and high expression of BLC in the target organs was attributed to the accumulation of mature myeloid DCs. The number of DCs in the circulation was increased around 5 months of age before the development of lupus nephritis and BLC was induced when peripheral blood DCs were cultured in the presence of TNF-α or IL-1β for 3 days. 18 Ansel et al. 39 demonstrated that BLC was essential for B1 cell homing to the peritoneal cavity . Ectopic high expression of BLC in the target organs in aged BWF1 mice resulted in the defective B1 cell homing to the peritoneal cavity and in preferential migration of B1 cells to the target organs. 19 BLC up-regulation and B cell infiltration in the thymus was readily detectable around 5 months of age before the establishment of lupus nephritis. Furthermore, B1 cells activated autologous thymic CD4 T cells in vitro in the presence of IL-2. 20 The activation of thymic CD4 T cells by B1 cells is MHC class II-dependent and there is no TCR Vβ skewing in activated T cells. On the other hand, CXCR5 + CD4 T cells with similar phenotype to follicular helper T cells are increased in aged BWF1 mice and enhance IgG anti-DNA antibody production by B1 cells (unpublished data). These results suggest that aberrant B1 cell trafficking to the target organs due to ectopic and high expression of BLC! CXCL13 plays a pivotal role in the pathogenesis of
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Environmental estrogens murine SLE (Fig. 4) .
HIGHER SUSCEPTIBILITY OF B1 CELLS TO ENDOCRINE DISRUPTORS THAN B2 CELLS
Because SLE has been markedly increasing for the past 30 years and B1 cells play a pivotal role in the pathogenesis of murine SLE, it is tempting to speculate that B 1 cells are possible targets for environmental estrogens. Indeed, IgM antibody production by B1 cells was significantly enhanced when cultured with estradiol ( E 2 ) , Diethylstilbestrol ( DES ) , or BisphenolA (BPA) (Fig. 5) . Interestingly, B1 cells derived from aged BWF1 mice developing lupus nephritis showed a higher response to environmental estrogens than those from young BWF1 mice. This is presumably due to higher expression of ER-α in B1 cells derived from aged BWF 1 mice than those from young BWF1 mice. It was noted that environmental estrogens did not affect B2 cells at all. An enhancing effect of environmental estrogens including DES and BPA on autoantibody production was further confirmed in vivo. E2, DES, and BPA implanted subcutaneouly in silastic tubes enhanced autoantibody production to bromelain-treated RBC. It was previously demonstrated that anti-Br-RBC Ab was mainly produced by B1 cells. 40 Implanted E2 and DES, but not BPA also enhanced IgG anti-dsDNA antibody production as well as IgG deposition in the glomeruli in the kidney. The failure of BPA to enhance IgG autoantibody production is likely attributed to weak estrogenic activity of BPA . 41 The estrogen level in diestrous female mice is around 20 30 pg! ml and increases to 100 200 pg! ml during estrus. It reaches to 5,000 10,000 pg! ml during pregnancy. Therefore, the serum levels of E2 in mice implanted with E2 silastic tubes are in the middle of those values between estrus and pregnancy. Long lasting release of BPA from implanted tubes was also observed although BPA concentration in the serum was much higher than that expected from environmental exposure in human population . Analysis of gene expression using DNA microarray will provide useful information that can be used to establish a screening system for environmental estrogens which may be involved in autoantibody production by B1 cells and to evaluate the pathological significance of those in the develop- 
CONCLUDING REMARKS
Environmental estrogens may possibly contribute to the marked increase in type-I allergic and autoimmune diseases. However, it is difficult to clarify the causality between environmental estrogens and diseases because it becomes evident only very slowly and indiscriminately. We should be ready to start a new strategy to protect human health from these kind of threats before it becomes too late. Hopefully, B1 cells will provide a good target to evaluate the biological significance of environmental estrogens in the development of autoimmune diseases (Fig. 6 ).
